EU/3/16/1787

Table of contents

About

On 18 November 2016, orphan designation (EU/3/16/1787) was granted by the European Commission to Lucane Pharma SA, France, for sodium benzoate for the treatment of argininosuccinic aciduria.

Key facts

Active substance
Sodium benzoate
Disease / condition
Treatment of argininosuccinic aciduria
Date of decision
18/11/2016
Outcome
Positive
Orphan decision number
EU/3/16/1787

Sponsor's contact details

Lucane Pharma SA
172 rue de Charonne
75011 Paris
France
Tel. + 33 1 53 868 750
E-mail: info@lucanepharma.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating